Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

CARISMA Therapeutics Inc (W2J.SG)

0.1689
-0.0052
(-2.99%)
At close: April 30 at 9:43:45 PM GMT+2
Loading Chart for W2J.SG
  • Previous Close 0.1741
  • Open 0.1644
  • Bid 0.1689 x --
  • Ask 0.1811 x --
  • Day's Range 0.1644 - 0.1689
  • 52 Week Range 0.1538 - 1.9070
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: W2J.SG

View More

Performance Overview: W2J.SG

Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

W2J.SG
60.67%
S&P 500 (^GSPC)
4.72%

1-Year Return

W2J.SG
88.64%
S&P 500 (^GSPC)
11.67%

3-Year Return

W2J.SG
70.50%
S&P 500 (^GSPC)
35.63%

5-Year Return

W2J.SG
70.50%
S&P 500 (^GSPC)
97.98%

Compare To: W2J.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: W2J.SG

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    7.29M

  • Enterprise Value

    -6.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.41

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: W2J.SG

View More

Company Insights: W2J.SG

Research Reports: W2J.SG

View More